Asciminib (ASC) demonstrates continued improvement in patient-reported outcomes (PROs) vs investigator-selected tyrosine kinase inhibitors (IS-TKIs) in newly diagnosed chronic myeloid leukemia (CML): ...

Global license provides American Regent, a wholly owned subsidiary of Daiichi Sankyo, with rights to commercialize Synoglide™ in the veterinary market in most countries of the world. Allegro retains ...

Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies showing Dupixent significantly ...

On 27 February 2025, Ramsay Générale de Santé acknowledged the announcement of its Australian reference shareholder Ramsay Health Care Limited regarding the review of its strategic options associated ...

Pennsylvania Perio & Implants today announced the reinforcement of its evidence-based framework for periodontal evaluation and dental implant assessment across its York and Hanover locations. Under ...

The JS001sc-002-III-NSCLC Study is a multi-center, open-label, randomized Phase 3 clinical study led by the principal investigator Professor Lin WU from Hunan Cancer Hospital. JS001sc-002-III-NSCLC is ...

The world-renowned, peer-reviewed, open-access Nature journal, Signal Transduction and Targeted Therapy, publishes original research on cutting-edge experimental and clinical advances on ...

For the quarter ending December 31, 2025, management expects gross revenue of more than US$30.0 million from sales of Ryoncil ® (remestemcel-L-rknd). This represents more than 37% increase on the ...

Clermont-Ferrand (France), 24 November 2025 (18h30 CET). CARBIOS (Euronext Growth Paris : ALCRB), announces the signing of two new multi-year commercial agreements with major players in beverage ...

Jeanette Yoffe Publishes "The Traumatized and At-Risk Youth Toolbox," Her Newest Guidebook With Over 160 Attachment-Informed Interventions for Working with Kids and Families in Foster Care and Beyond ...

The webcast of the fireside chat discussion will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days ...

8th Annual Evercore Healthcare Conference Date: Wednesday, December 3, 2025 at 8:45 am E.T. Location: Coral Gables, FL Presenter: Chief Executive Officer, Talat Imran, and Chief Financial Officer, ...